These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 7876321)

  • 21. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
    Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
    Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization.
    Eijken M; Koedam M; van Driel M; Buurman CJ; Pols HA; van Leeuwen JP
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):87-93. PubMed ID: 16406260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and clinical perspectives on skeletal insulin-like growth factor I.
    Delany AM; Pash JM; Canalis E
    J Cell Biochem; 1994 Jul; 55(3):328-33. PubMed ID: 7962164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of glucocorticoid action in bone.
    Canalis E; Delany AM
    Ann N Y Acad Sci; 2002 Jun; 966():73-81. PubMed ID: 12114261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
    Koutsilieris M; Reyes-Moreno C; Sourla A; Dimitriadou V; Choki I
    Anticancer Res; 1997; 17(3A):1461-5. PubMed ID: 9179184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
    Kuo PL; Hsu YL; Chang CH; Chang JK
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoids exert context-dependent effects on cells of the joint in vitro.
    Madsen SH; Andreassen KV; Christensen ST; Karsdal MA; Sverdrup FM; Bay-Jensen AC; Henriksen K
    Steroids; 2011 Dec; 76(13):1474-82. PubMed ID: 21855558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures.
    Centrella M; Rosen V; Wozney JM; Casinghino SR; McCarthy TL
    J Cell Biochem; 1997 Dec; 67(4):528-40. PubMed ID: 9383711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a PTH regulated gene selectively induced in vivo during PTH-mediated bone formation.
    Robinson JA; Susulic V; Liu YB; Taylor C; Hardenburg J; Gironda V; Zhao W; Kharode Y; McLarney S; Bai Y; Malone DP; Murrills R; Bex F
    J Cell Biochem; 2006 Aug; 98(5):1203-20. PubMed ID: 16514668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells.
    Cao L; Bu R; Oakley JI; Kalla SE; Blair HC
    J Cell Biochem; 2003 May; 89(1):152-64. PubMed ID: 12682916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth factors to stimulate bone formation.
    Baylink DJ; Finkelman RD; Mohan S
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S565-72. PubMed ID: 8122528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-receptorial regulation of steroid hormones in bone cells: insights on glucocorticoid-induced osteoporosis.
    Pierotti S; Gandini L; Lenzi A; Isidori AM
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):292-9. PubMed ID: 17950597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.
    Rauch A; Seitz S; Baschant U; Schilling AF; Illing A; Stride B; Kirilov M; Mandic V; Takacz A; Schmidt-Ullrich R; Ostermay S; Schinke T; Spanbroek R; Zaiss MM; Angel PE; Lerner UH; David JP; Reichardt HM; Amling M; Schütz G; Tuckermann JP
    Cell Metab; 2010 Jun; 11(6):517-31. PubMed ID: 20519123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing's syndrome and may play a role in glucocorticoid-induced osteoporosis.
    Lekva T; Bollerslev J; Kristo C; Olstad OK; Ueland T; Jemtland R
    J Clin Endocrinol Metab; 2010 Jan; 95(1):246-55. PubMed ID: 19875485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Glucocorticoid and Bone. The effect of glucocorticoid and PTH in osteoblast apoptosis and differentiation via interleukin 11 expression].
    Endo I
    Clin Calcium; 2014 Sep; 24(9):1321-8. PubMed ID: 25177004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice.
    Yang P; Lv S; Wang Y; Peng Y; Ye Z; Xia Z; Ding G; Cao X; Crane JL
    Bone; 2018 Sep; 114():1-13. PubMed ID: 29800693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Continuous remodeling of the skeleton. Growth factors and cytokines direct the activity].
    Ljunggren O; Ljunghall S; Lerner U
    Lakartidningen; 1995 May; 92(20):2094-6, 2099-100. PubMed ID: 7760596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of glucocorticoid-induced osteoporosis.
    Canalis E
    Curr Opin Rheumatol; 2003 Jul; 15(4):454-7. PubMed ID: 12819474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid receptor signaling in bone cells.
    Moutsatsou P; Kassi E; Papavassiliou AG
    Trends Mol Med; 2012 Jun; 18(6):348-59. PubMed ID: 22578718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.